A convenient qualitative and quantitative method to investigate RHD-RHCE hybrid genes

Transfusion

Volumn 53, Issue 11 PART 2, 2013, Pages 2974-2982

  Fichou, Yann ^a   Le Maréchal, Cédric ^b   Bryckaert, Laurence ^b   Dupont, Isabelle ^b   Jamet, Déborah ^b   Chen, Jian Min ^b   Férec, Claude ^a  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUORESCENT DYE; PRIMER DNA; RHCE PROTEIN, HUMAN; RHO(D) ANTIGEN; BLOOD GROUP RHESUS SYSTEM;

ALLELE; ARTICLE; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; GENE DOSAGE; GENETICS; HETEROZYGOTE DETECTION; HUMAN; METHODOLOGY; MOSAICISM; MULTIPLEX POLYMERASE CHAIN REACTION; VALIDATION STUDY; DIAGNOSTIC USE; PROCEDURES;

ALLELES; BLOOD GROUPING AND CROSSMATCHING; DNA PRIMERS; FLUORESCENT DYES; GENE DOSAGE; HETEROZYGOTE DETECTION; HUMANS; MOSAICISM; MULTIPLEX POLYMERASE CHAIN REACTION; RH-HR BLOOD-GROUP SYSTEM;

EID: 84893190566     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12179     Document Type: Article

References (33)

1. Avent ND, Ridgwell K, Tanner MJ, Anstee DJ. cDNA cloning of a 30 kDa erythrocyte membrane protein associated with Rh (Rhesus)-blood-group-antigen expression. Biochem J 1990;271: 821-5.
2. Chérif-Zahar B, Bloy C, Le Van Kim C, Blanchard D, Bailly P, Hermand P, Salmon C, Cartron JP, Colin Y. Molecular cloning and protein structure of a human blood group Rh polypeptide. Proc Natl Acad Sci U S A 1990;87: 6243-7.
3. Colin Y, Chérif-Zahar B, Le Van Kim C, Raynal V, Van Huffel V, Cartron JP. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78: 2747-52.
4. Le Van Kim C, Mouro I, Chérif-Zahar B, Raynal V, Cherrier C, Cartron JP, Colin Y. Molecular cloning and primary structure of the human blood group RhD polypeptide. Proc Natl Acad Sci U S A 1992;89: 10925-9.
5. Faas BH, Beckers EA, Wildoer P, Ligthart PC, Overbeeke MA, Zondervan HA, von dem Borne AE, van der Schoot CE. Molecular background of VS and weak C expression in blacks. Transfusion 1997;37: 38-44.
6. Pham BN, Peyrard T, Juszczak G, Dubeaux I, Gien D, Blancher A, Cartron JP, Rouger P, Le Pennec PY. Heterogeneous molecular background of the weak C, VS+, hr B-, Hr B- phenotype in black persons. Transfusion 2009;49: 495-504.
7. Matassi G, Chérif-Zahar B, Mouro I, Cartron JP. Characterization of the recombination hot spot involved in the genomic rearrangement leading to the hybrid D-CE-D gene in the D(VI) phenotype. Am J Hum Genet 1997;60: 808-17.
8. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA. Three molecular structures cause rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998;91: 2157-68.
9. Omi T, Takahashi J, Tsudo N, Okuda H, Iwamoto S, Tanaka M, Seno T, Tani Y, Kajii E. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype. Biochem Biophys Res Commun 1999;254: 786-94.
10. Esteban R, Montero R, Flegel WA, Wagner FF, Subirana L, Parra R, Ribera A, Nogués N. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion 2006;46: 616-23.
11. Maaskant-vanWijk PA, Faas BH, de Ruijter JA, Overbeeke MA, von dem Borne AE, van Rhenen DJ, van der Schoot CE. Genotyping of RHD by multiplex polymerase chain reaction analysis of six RHD-specific exons. Transfusion 1998;38: 1015-21.
12. Le Maréchal C, Guerry C, Benech C, Burlot L, Cavelier B, Porra V, Delamaire M, Férec C, Chen JM. Identification of 12 novel RHD alleles in western France by denaturing high-performance liquid chromatography analysis. Transfusion 2007;47: 858-63.
13. Chen JM, Fichou Y, Jamet D, Dupont I, Cooper DN, Le Maréchal C, Férec C. Small deletions occurred within the RHD coding sequence: report of two novel events and a survey of the underlying functional and mutational mechanisms. Transfusion 2012;53: 206-10.
14. Fichou Y, Le Maréchal C, Bryckaert L, Guerry C, Bénech C, Dupont I, Jamet D, Férec C, Chen JM. Variant screening of the RHD gene in a large cohort of subjects with D phenotype ambiguity: report of 17 novel rare alleles. Transfusion 2012;52: 759-64.
15. Fichou Y, Chen JM, Le Maréchal C, Jamet D, Dupont I, Chuteau C, Durousseau C, Loirat MJ, Bailly P, Férec C. Weak D caused by a founder deletion in the RHD gene. Transfusion 2012;52: 2348-55.
16. Fichou Y, Le Maréchal C, Jamet D, Bryckaert L, Ka C, Audrézet MP, Le Gac G, Dupont I, Chen JM, Férec C. Establishment of a medium-throughput approach for the genotyping of RHD variants and report of nine novel rare alleles. Transfusion 2013;53: 1821-8.
17. Shimizu M, Kosaka N, Shimada T, Nagahata T, Iwasaki H, Nagai H, Shiba T, Emi M. Universal fluorescent labeling (UFL) method for automated microsatellite analysis. DNA Res 2002;9: 173-8.
18. Guo DC, Milewicz DM. Methodology for using a universal primer to label amplified DNA segments for molecular analysis. Biotechnol Lett 2003;25: 2079-83.
19. Fichou Y, Génin E, Le Maréchal C, Audrézet MP, Scotet V, Férec C. Estimating the age of CFTR mutations predominantly found in Brittany (Western France). J Cyst Fibros 2008;7: 168-73.
20. Casilli F, Di Rocco ZC, Gad S, Tournier I, Stoppa-Lyonnet D, Frebourg T, Tosi M. Rapid detection of novel BRCA1 rearrangements in high-risk breast-ovarian cancer families using multiplex PCR of short fluorescent fragments. Hum Mutat 2002;20: 218-26.
21. Arce MA, Thompson ES, Wagner S, Coyne KE, Ferdman BA, Lublin DM. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood 1993;82: 651-5.
22. Mouro I, Colin Y, Chérif-Zahar B, Cartron JP, Le Van Kim C. Molecular genetic basis of the human Rhesus blood group system. Nat Genet 1993;5: 62-5.
23. Singleton BK, Green CA, Avent ND, Martin PG, Smart E, Daka A, Narter-Olaga EG, Hawthorne LM, Daniels G. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95: 12-8.
24. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
25. Gassner C, Doescher A, Drnovsek TD, Rozman P, Eicher NI, Legler TJ, Lukin S, Garritsen H, Kleinrath T, Egger B, Ehling R, Körmöczi GF, Kilga-Nogler S, Schoenitzer D, Petershofen EK. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005;45: 527-38.
26. Krog GR, Clausen FB, Dziegiel MH. Quantitation of RHD by real-time polymerase chain reaction for determination of RHD zygosity and RHD mosaicism/chimerism: an evaluation of four quantitative methods. Transfusion 2007; 47: 715-22.
27. Kallioniemi A. CGH microarrays and cancer. Curr Opin Biotechnol 2008;19: 36-40.
28. van der Veken LT, Buijs A. Array CGH in human leukemia: from somatics to genetics. Cytogenet Genome Res 2011; 135: 260-70.
29. Edelmann L, Hirschhorn K. Clinical utility of array CGH for the detection of chromosomal imbalances associated with mental retardation and multiple congenital anomalies. Ann N Y Acad Sci 2009;1151: 157-66.
30. Aradhya S, Lewis R, Bonaga T, Nwokekeh N, Stafford A, Boggs B, Hruska K, Smaoui N, Compton JG, Richard G, Suchy S. Exon-level array CGH in a large clinical cohort demonstrates increased sensitivity of diagnostic testing for Mendelian disorders. Genet Med 2012;14: 594-603.
31. Lichtenbelt KD, Knoers NV, Schuring-Blom GH. From karyotyping to array-CGH in prenatal diagnosis. Cytogenet Genome Res 2011;135: 241-50.
32. Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art 2011. Hum Genet 2012;131: 175-86.
33. Haer-Wigman L, Veldhuisen B, Jonkers R, Lodén M, Madgett TE, Avent ND, de Haas M, van der Schoot CE. RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification. Transfusion 2013;53: 1559-74.